PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
about
Positron emission tomography imaging in multiple sclerosis-current status and future applicationsFibromyalgia symptoms are reduced by low-dose naltrexone: a pilot studyThe positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disordersTranslocator protein 18 kDa (TSPO): molecular sensor of brain injury and repairImaging multiple sclerosis and other neurodegenerative diseasesNeuroimaging biomarkers of neurodegenerative diseases and dementiaPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesImaging neuroinflammation in multiple sclerosis using TSPO-PETIn vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's diseaseNeuroinflammatory component of gray matter pathology in multiple sclerosisPositron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseaseNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state.Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET dataImaging Neuroinflammation - from Bench to Bedside.Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesTowards molecular imaging of multiple sclerosis.Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a reviewSynthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa).A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndromeAbnormalities of cerebral perfusion in multiple sclerosis.Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis.Translocator protein PET imaging for glial activation in multiple sclerosisLoss of Metabotropic Glutamate Receptor 5 Function on Peripheral Benzodiazepine Receptor in Mice Prenatally Exposed to LPS.Noninvasive molecular imaging of neuroinflammationThe high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityDecreased microglial activation in MS patients treated with glatiramer acetate.Clinical aspects of inflammation in Alzheimer's disease.The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammationHippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats.PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS
P2860
Q22242393-1A424093-6FC7-432B-AB36-288E1D84E742Q24630189-338EB010-7BF4-4FF5-88FC-7EAE0A6CF999Q24641816-CDD35E08-95A6-4439-834D-C2C3BA1CEDAFQ24644752-F23451D7-CB09-4B80-B4C4-24252F4D4133Q26826889-8363A6F2-DAF3-4D24-A0BC-26A8BFAD5930Q27691820-8E761AD8-FEEB-42D6-8201-0D515B5715C7Q28078621-3E82A3C6-10D3-4C0B-BEB6-C9FCBC651325Q28084625-81D87E36-953F-418F-8533-D98ADD93EED5Q28274003-719507C1-F849-4ABB-A1B6-FE223DA9996CQ29398383-56ACC151-F3F5-4AFE-A3F7-A1C1B7B2D4FEQ30497749-8A10F7D4-834C-42D1-9DE6-5B64D726579CQ30576477-C143C9E3-D3DE-4B87-BD95-6A5872837BFBQ30581773-B5A82F76-BAD9-4960-8F1D-3D7354617A45Q30649552-3E60974E-667B-47DF-9B2F-F6F39D23F624Q30785495-60FAF33F-60FA-4273-9258-421C057D0C0FQ30881154-44FCAB87-E25D-49AF-B4F6-E221AA4C547AQ30983016-65B69871-79D1-4B4D-A103-1754C2A9811AQ30989935-5D7E9931-0DFA-466E-AC79-BC5EFE9E1592Q33624586-32D3C82B-55CB-4BC0-88F6-B52619F3C56FQ33787779-3E97EAB9-60B9-4C5F-8BF6-A425471FEF9FQ34158137-CD92C3A3-7ED2-4B1C-9D18-020D14B77D6EQ34408079-578EE89C-2920-4ED6-8C2F-6BC82A0154C8Q34435657-3D40B133-0726-4E19-A907-29059700EDD0Q34635445-C9281004-5A5B-4EC1-8854-3BF9DE68F36CQ35208026-23879382-F7DB-46BF-996C-BE4A07217338Q35248914-66BBCC40-5F79-4444-A534-677618AFF5D0Q35482990-4D9634F0-C881-4EF9-A9D0-4DF3D9193C72Q35613716-47F1F449-57E8-4E13-B814-6755195C7315Q35671432-7D100EC5-0F7C-4CDB-891E-53079FA1EE44Q35831877-6541E78F-84F4-44DC-ABB6-FD00C6E2C81AQ36079268-17F81DD7-959B-4797-9D40-F8E34A669D70Q36094332-BC646403-C1D8-4FA3-A914-579E2EAEBB0CQ36146941-E5724573-1F8D-4F59-A76A-5F8E2021E279Q36338408-F583EB43-6741-40BA-B1C2-FAAF76D614B2Q36364213-0945941E-4165-4746-826E-823F982D3B47Q36677808-E38FA7B1-3683-463A-94DD-FFF455EEC322Q36684216-CE2A4B3E-4EB5-4ED3-B0F8-F6A27B69CC6CQ37032733-846A27DF-C04E-4919-9FED-E79A7EB00C1CQ37144048-6F4C68E0-932A-4996-8C48-AF1402DE3D81Q37221685-A1F317B6-099D-4110-A5C1-A1C41047CAE2
P2860
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@en
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@nl
type
label
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@en
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@nl
prefLabel
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@en
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@nl
P2093
P2860
P921
P1476
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
@en
P2093
J C Debruyne
J L De Reuck
J Versijpt
K J Van Laere
K Strijckmans
P2860
P304
P356
10.1046/J.1468-1331.2003.00571.X
P577
2003-05-01T00:00:00Z